Plenary Keynote Program
THURSDAY, JUNE 23
3:45 pm Chairperson's Remarks
Nadeem Sarwar, PhD, Global Head, Genomic Strategies & Global Head, Digital Therapeutics Strategies, Eisai
3:50 pm Plenary Keynote Introduction (Opportunity Available)
4:00 pm Talk Title to be Announced
Nadeem Sarwar, PhD, Global Head, Genomic Strategies & Global Head, Digital Therapeutics Strategies, Eisai
4:30 pm Keynote Panel: Celebrating 20 Years of Innovation: Discussion with Past Keynote Speakers
Moderator:
Nadeem Sarwar, PhD, Global Head, Genomic Strategies & Global Head, Digital Therapeutics Strategies, Eisai
Panelists:
Bino John, PhD, Global Team Leader, Director, Data Science and AI Group in Clinical Pharmacology and Safety Sciences, AstraZeneca
Zhen Su, MD, MBA, CEO, Marengo Therapeutics
Patrick Walters, PhD, Chief Data Officer, Relay Therapeutics, Inc.
Peter V. Henstock, PhD, Machine Learning & AI Lead, Software Engineering & Statistics & Visualization, Pfizer, Inc.
FRIDAY, JUNE 24
8:05 am Plenary Keynote Introduction (Sponsorship Opportunity Available)
8:15 am Programmable Organoids with Mammalian Synthetic Biology
Ron Weiss, PhD, Professor, Biological Engineering, Massachusetts Institute of Technology
8:45 am Microphysiological Systems – Looking to the Future
Lucie Low, PhD, Scientific Program Manager, NCATS, NIH
Microphysiological systems – also known as “tissue chips” or “organs-on-chips” –
have seen extensive development over the last decade and show great promise for use in understanding diseases and development of therapeutics. Many areas of potential use are yet to be recognized and challenges remain to be overcome for more widespread
adoption of the technology. This talk will briefly cover some highlights of the NIH Tissue Chip program from the last decade and detail broader challenges and opportunities that remain in the field.